| abstract |
The present invention provides a method for treating malignant gliomas, particularly glioblastoma multiforme, which is a rare cancer, has no satisfactory treatment method at present, and has a poor prognosis. A dose of 1-20 mg of temozolomide per kg of the patient's body weight per day, or a dose of 0.1-10 mg of paclitaxel per kg of the patient's body weight per day, and per kg of the patient's body weight A pharmaceutical composition for the treatment of malignant glioma, which is combined with 0.01-10 mg of macitentan. [Selection figure] None |